National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Aromatherapy and Essential Oils (PDQ®)
Patient Version   Health Professional Version   Last Modified: 05/29/2008



Purpose of This PDQ Summary






Overview






General Information






History






Laboratory/Animal/Preclinical Studies






Human/Clinical Studies






Adverse Effects






Overall Level of Evidence for Aromatherapy and Essential Oils






Changes to This Summary (05/29/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Changes to This Summary (05/29/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Human/Clinical Studies

Added text to state that antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus, are an increasing problem worldwide, causing intractable wound infections (cited Sherry et al. as reference 9).

Added text to state that of the two topical MRSA eradication regimens that were compared in hospital patients, both were administered for 5 days, the tea tree oil regimen showed a slightly higher clearance rate than the standard treatment, but the difference was not significant.

Adverse Effects

Added text to state that there is a theoretical concern for women at high risk for hormonally sensitive breast cancer when using lavender and tea tree oils (cited Henley et al. as reference 3).

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov